Cost-Utility Analysis of Pharmaceutical Care Intervention Versus Usual Care in Management of Nigerian Patients with Type 2 Diabetes-Reference-Cited by-同舟云学术

Cost-Utility Analysis of Pharmaceutical Care Intervention Versus Usual Care in Management of Nigerian Patients with Type 2 Diabetes

Published:2013-09 Issue:2 Volume:2 Page:189-198
ISSN:2212-1099
Container-title:Value in Health Regional Issues
language:en
Short-container-title:Value in Health Regional Issues

Author:

Adibe Maxwell O.,Aguwa Cletus N.,Ukwe Chinwe V.

Publisher

Elsevier BV

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)

Reference39 articles.

1. National Institute for Clinical Excellence and its value judgments;Rawlins;BMJ,2004

2. Measurement of health state utilities for economic appraisal: a review;Torrance;J Health Econ,1986

3. Methods for the Economic Evaluation of Health Care Programmes;Drummond,1997

4. The pattern of presentation of foot lesions in Nigerian diabetic patients;Akanji;West Afr J Med,1990

5. American Diabetes Association. National Diabetes Fact Sheet. Available from: http://www.diabetes.org/main/info/facts/factsna tl.jsp. [Accessed December 15, 2002].

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Cost-Effectiveness of Pharmacist Care in Diabetes Management: A Systematic Review;Diabetes Therapy;2023-11-14

3. Economic evaluations of non-communicable diseases conducted in Sub-Saharan Africa: a critical review of data sources;Cost Effectiveness and Resource Allocation;2023-08-28

4. A systematic review of economic evaluations of pharmacist services;International Journal of Pharmacy Practice;2023-08-06

5. Implementation of non-insulin-dependent diabetes self-management education (DSME) in LMICs: a systematic review of cost, adoption, acceptability, and fidelity in resource-constrained settings;Frontiers in Health Services;2023-06-13